Lung cancer showdown: surgery vs. radiation in High-Risk patients
NCT ID NCT07432802
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two treatments for high-risk patients with early-stage non-small cell lung cancer: minimally invasive surgery (wedge resection) and stereotactic body radiation therapy (SBRT). The goal is to see which approach leads to longer disease-free survival and better quality of life. The trial will enroll 182 participants across Denmark and follow them for up to 5 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Stereotactic body radiation therapy (SBRT) or minimally invasive wedge resection surgery
- What this could lead to
- If this trial succeeds, it could provide clear evidence on whether radiation or surgery is better for controlling early-stage lung cancer in high-risk patients, helping doctors make more informed treatment decisions.
- What could go wrong
- This trial is not yet recruiting and has a relatively small size (182 participants). Results may not apply to all patients, and both treatments carry risks like complications from surgery or side effects from radiation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aalborg University Hospital
Aalborg, Aalborg, Denmark
-
Aarhus University Hospital
Aarhus N, 8200, Denmark
-
Odense University Hospital
Odense, 5000, Denmark
-
Rigshospitalet
Copenhagen, Copenhagen, 2100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat cancers?
- Family support may be key to easing lung cancer surgery stress
- Can a drop of blood predict disease years before it strikes?
- Blood, urine, and stool may hold the key to predicting a serious side effect of lung cancer treatment
- Microwave ablation vs. radiotherapy: which Non-Surgical option works best for early lung cancer?
- Double-Targeted therapy aims to outsmart Hard-to-Treat lung cancer